Ultimovacs ASA Reports Third Quarter 2024 Financial Results And Provides General Business Update
(MENAFN- GlobeNewsWire - Nasdaq) Oslo, November 6, 2024: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its third quarter 2024 results today. Conference …